Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Topsun is a prominent Chinese pharmaceutical enterprise that specializes in the research, development, manufacturing, and distribution of a diverse range of healthcare products. The company's portfolio is divided between modern chemical pharmaceuticals and Traditional Chinese Medicine (TCM), with a strong focus on therapeutic areas such as cardiovascular health, anti-infectives, and respiratory diseases. Headquartered in Chengdu, Topsun operates several large-scale GMP-certified manufacturing facilities and maintains a significant presence in the domestic Chinese market. The company is publicly traded on the Shenzhen Stock Exchange and is recognized for its integration of industrial manufacturing with scientific research. Beyond finished dosage forms, Topsun is also a key producer of active pharmaceutical ingredients (APIs) and health supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Topsun.